The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20110960: Sunoco Logistics Partners L.P.; Sunoco, Inc.
20110956: Honeywell International Inc.; Sunoco, Inc.
20110954: Wayzata Opportunities Fund II, L.P.; Entegra Power Group LLC
Legacy Learning Systems, Inc., et al., In the Matter of
20110880: Constellation Energy Group, Inc.; MXenergy Holdings Inc.
Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules
Grifiols, S.A. and Talecris Biotherapeutics Holdings Corp.; Analysis of Agreement Containing Consent Orders to Aid Public Comment: Proposed Consent Agreement
20110957: Golden Gate Capital Opportunity Fund, L.P.; California Pizza Kitchen, Inc.
20110946: Kinove Luxembourg Holdings I S.a.r.l. ("KLH I"); Evonik Industries AG
20110923: Leeds Equity Partners V, L.P.; Nobel Learning Communities, Inc.
20110901: Kratos Defense & Security Solutions, Inc.; Integral Systems, Inc.
Hikma Pharmaceuticals PLC, In the Matter of (Baxter)
The Commission required Hikma Pharmaceuticals PLC (Hikma) to divest two generic injectable pharmaceuticals – phenytoin and promethazine – as part of a settlement allowing it to acquire certain assets from Baxter Healthcare Corporation, Inc. (Baxter). Hikma proposes to acquire Baxter’s entire generic injectable pharmaceutical business for $111.5 million, including Baxter’s Cherry Hill, New Jersey, manufacturing facility and a warehouse and distribution center in Memphis, Tennessee. Phenytoin is an anti-convulsant drug used to control and prevent seizures during or after surgery and Promethazine is used to prevent some types of allergies or allergic reactions, to prevent or control motion sickness, nausea, vomiting, and dizziness, and to help patients go to sleep and control their pain or anxiety before or after surgery.